生活型疾病治療藥物市場：依治療類型（皮膚科、失眠、肥胖）、劑型（乳霜、凝膠、口服糖漿）、分佈 - 全球預測 2023-2030

全球生活型態相關疾病藥物市場預計到2023年將大幅成長至209.4億美元，年複合成長率為5.80%，預計到2030年將達到驚人的311.2億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球生活型態相關疾病藥物市場至關重要。透過檢驗業務策略和產品滿意度等關鍵指標，它可以對供應商進行全面評估，使用戶能夠根據自己的特定需求做出資訊的決策。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發地區、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.生活型態相關疾病藥物的全球市場規模及預測為何？

2.在預測期內，COVID-19對全球生活型態相關疾病治療藥物市場的阻礙因素與影響為何？

3.全球生活型態相關疾病藥物市場應在預測期內投資哪些產品/細分/應用/領域？

4.您在全球生活型態相關疾病藥物市場的競爭策略是什麼？

5.全球生活方式疾病藥物市場的技術趨勢和法律規範是什麼？

6.全球生活習慣病藥物市場主要廠商的市佔率為何？

7.什麼型態和策略性舉措被認為適合進入生活型態相關疾病藥物的全球市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

• 市場動態
  • 促進因素
    • 採用不健康的飲食和久坐的生活方式
    • 增強個人健身意識與健康意識
    • 性功能障礙和荷爾蒙失衡增加
  • 抑制因素
    • 產品成本高
  • 機會
    • 增加藥物開發的研究和開發
    • 美容和護膚治療支出增加
  • 任務
    • 與生活型態相關疾病藥物相關的不良反應
• 市場趨勢
• COVID-19 的累積影響
• 俄羅斯-烏克蘭衝突的累積影響
• 高通膨的累積效應
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 法律規範
• 客戶客製化

第6章 依治療類型分類的生活型態疾病治療藥物市場

• 皮膚科
• 失眠
• 肥胖
• 性功能障礙
• 抽煙
• 女性健康

第7章 生活型態疾病治療藥物市場：依型態

• 奶油
• 凝膠
• 口服糖漿
• 藥片

第8章 生活型態疾病治療藥物市場分佈

• 醫院藥房
• 線上通路
• 零售藥房

第9章 北美和南美生活方式相關疾病治療藥物市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第10章 亞太地區生活風格相關疾病藥物市場

• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第11章歐洲/中東/非洲生活型態相關疾病藥品市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第12章競爭形勢

• FPNV定位矩陣
• 市佔率分析：主要企業
• 競爭情境分析：主要企業

第13章上市公司名單

第14章附錄

• 討論指南
• 關於許可證和定價

The Global Lifestyle Drugs Market is forecasted to grow significantly, with a projected USD 20.94 billion in 2023 at a CAGR of 5.80% and expected to reach a staggering USD 31.12 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Lifestyle Drugs Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Lifestyle Drugs Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Therapeutic Type, market is studied across Dermatology, Insomnia, Obesity, Sexual Dysfunction, Smoking, and Women's Health. The Women's Health is projected to witness significant market share during forecast period.

Based on Form, market is studied across Creams, Gels, Oral Syrups, and Tablets. The Gels is projected to witness significant market share during forecast period.

Based on Distribution, market is studied across Hospital Pharmacies, Online Channels, and Retail Pharmacies. The Online Channels is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Lifestyle Drugs Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Lifestyle Drugs Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Lifestyle Drugs Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Lifestyle Drugs Market?

4. What is the competitive strategic window for opportunities in the Global Lifestyle Drugs Market?

5. What are the technology trends and regulatory frameworks in the Global Lifestyle Drugs Market?

6. What is the market share of the leading vendors in the Global Lifestyle Drugs Market?

7. What modes and strategic moves are considered suitable for entering the Global Lifestyle Drugs Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Lifestyle Drugs Market, by Therapeutic Type, 2022 vs 2030
• 4.3. Lifestyle Drugs Market, by Form, 2022 vs 2030
• 4.4. Lifestyle Drugs Market, by Distribution, 2022 vs 2030
• 4.5. Lifestyle Drugs Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Adoption of unhealthy eating habits and sedentary lifestyle
    • 5.1.1.2. Increasing awareness regarding personal fitness and health consciousness
    • 5.1.1.3. Rise in sexual disorders and hormonal imbalance
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of products
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing R&D for drug developments
    • 5.1.3.2. Rising expenditure on beauty and skin care therapeutics
  • 5.1.4. Challenges
    • 5.1.4.1. Adverse effects associated with the lifestyle drugs
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Lifestyle Drugs Market, by Therapeutic Type

• 6.1. Introduction
• 6.2. Dermatology
• 6.3. Insomnia
• 6.4. Obesity
• 6.5. Sexual Dysfunction
• 6.6. Smoking
• 6.7. Women's Health

7. Lifestyle Drugs Market, by Form

• 7.1. Introduction
• 7.2. Creams
• 7.3. Gels
• 7.4. Oral Syrups
• 7.5. Tablets

8. Lifestyle Drugs Market, by Distribution

• 8.1. Introduction
• 8.2. Hospital Pharmacies
• 8.3. Online Channels
• 8.4. Retail Pharmacies

9. Americas Lifestyle Drugs Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Lifestyle Drugs Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Lifestyle Drugs Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. LIFESTYLE DRUGS MARKET RESEARCH PROCESS
• FIGURE 2. LIFESTYLE DRUGS MARKET SIZE, 2022 VS 2030
• FIGURE 3. LIFESTYLE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2022 VS 2030 (%)
• FIGURE 5. LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2022 VS 2030 (%)
• FIGURE 6. LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2022 VS 2030 (%)
• FIGURE 7. LIFESTYLE DRUGS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 8. LIFESTYLE DRUGS MARKET DYNAMICS
• FIGURE 9. LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. LIFESTYLE DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 17. LIFESTYLE DRUGS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. LIFESTYLE DRUGS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. LIFESTYLE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 5. LIFESTYLE DRUGS MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. LIFESTYLE DRUGS MARKET SIZE, BY INSOMNIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. LIFESTYLE DRUGS MARKET SIZE, BY OBESITY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. LIFESTYLE DRUGS MARKET SIZE, BY SEXUAL DYSFUNCTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. LIFESTYLE DRUGS MARKET SIZE, BY SMOKING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. LIFESTYLE DRUGS MARKET SIZE, BY WOMEN'S HEALTH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 12. LIFESTYLE DRUGS MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. LIFESTYLE DRUGS MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. LIFESTYLE DRUGS MARKET SIZE, BY ORAL SYRUPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. LIFESTYLE DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 17. LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. LIFESTYLE DRUGS MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. LIFESTYLE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 30. CANADA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 31. CANADA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 32. CANADA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 47. CHINA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 48. CHINA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 49. CHINA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 50. INDIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 51. INDIA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 52. INDIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 102. ITALY LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 103. ITALY LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 104. ITALY LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 114. POLAND LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 115. POLAND LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 116. POLAND LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 117. QATAR LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 118. QATAR LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 119. QATAR LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 147. LIFESTYLE DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 148. LIFESTYLE DRUGS MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 149. LIFESTYLE DRUGS MARKET LICENSE & PRICING